BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $166,800 | -96.0% | 20,000 | -94.6% | 0.01% | -96.3% |
Q4 2022 | $4,216,604 | -24.3% | 367,300 | -16.9% | 0.37% | -31.5% |
Q3 2022 | $5,568,000 | +19.1% | 441,900 | 0.0% | 0.55% | +28.5% |
Q2 2022 | $4,675,000 | -35.2% | 441,900 | -0.3% | 0.42% | -24.4% |
Q1 2022 | $7,210,000 | +15.7% | 443,400 | -1.4% | 0.56% | +28.9% |
Q4 2021 | $6,230,000 | -2.1% | 449,800 | +1.6% | 0.44% | -15.7% |
Q3 2021 | $6,364,000 | -7.8% | 442,900 | +1.4% | 0.52% | -5.7% |
Q2 2021 | $6,904,000 | +55.8% | 436,690 | +0.2% | 0.55% | +31.1% |
Q1 2021 | $4,432,000 | +98.2% | 435,790 | +45.2% | 0.42% | +79.4% |
Q4 2020 | $2,236,000 | +272.0% | 300,190 | +71.5% | 0.23% | +228.2% |
Q3 2020 | $601,000 | +214.7% | 175,000 | +337.5% | 0.07% | +184.0% |
Q2 2020 | $191,000 | – | 40,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |